DEEPVESSEL Plaque

by Keya Medical Technology Co., Ltd.  · Based in China → — FDA-cleared AI-powered CCTA analysis to quantify plaque burden, characterize plaque, and assess coronary stenosis.
Cardiology Cardiothoracic Surgery Radiology

Regulatory Status Disclosed

Overview

DEEPVESSEL Plaque by Keya Medical Technology Co., Ltd. is an AI-powered medical tool designed for the analysis of coronary computed tomography angiography (CCTA) studies.

  • What it does:The tool characterizes and quantifies coronary atherosclerotic plaque and stenosis from previously acquired CCTA images. It provides quantitative measurements including total plaque volume, calcified and non-calcified plaque volume, low-density plaque volume, plaque burden, and stenosis severity, along with CAD-RADS stenosis categorization.
  • Who it is for:DEEPVESSEL Plaque is intended for qualified clinicians to assess the presence and extent of coronary artery disease (CAD) in adults with suspected or known CAD. This includes specialties such as cardiology and radiology, and it can be utilized in care settings where CCTA studies are performed and interpreted.
  • How it fits a clinical or practice workflow:The workflow involves secure transfer of previously acquired CCTA DICOM data. Deep-learning-based segmentation is then performed and reviewed by trained analysts. Finally, quantitative and visual clinical reports are delivered for review by the clinician.
  • Notable capabilities:DEEPVESSEL Plaque offers detailed vessel- and patient-level plaque volumes, burden, composition, and stenosis assessment through visual clinical reports.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered coronary plaque analysis
  • Quantifies plaque burden
  • Characterizes plaque composition (calcified, non-calcified, low-density)
  • Assesses coronary stenosis
  • Provides quantitative plaque measurements
  • Generates visual clinical reports
  • Segments coronary arteries, vessel walls, and lumen structures
  • Supports clinical decision-making for coronary artery disease (CAD)
  • Compatible with previously acquired CCTA studies
  • Integration with DEEPVESSEL FFR for comprehensive cardiac analysis

Use Cases

  • Assessing the presence and extent of coronary atherosclerosis
  • Evaluating coronary artery disease (CAD) in adults with suspected or known CAD
  • Supporting clinical decision-making for patient management strategies
  • Complementing expert CCTA interpretation with standardized, scalable AI-assisted plaque assessment

What Physicians Need to Know

Cardiac CT/MRI Analysis
DEEPVESSEL Plaque is AI-assisted software that characterizes and quantifies coronary plaque and stenosis from previously acquired CCTA data.
Coronary Artery Assessment
Provides quantitative measurements and visual clinical reports to support qualified clinicians in coronary artery assessment, including total plaque volume, calcified plaque volume, and non-calcified plaque volume.
AHA/ACC Guideline Alignment
Evaluated against consensus from three Level III expert readers for plaque quantification and stenosis categorization, achieving 0.810 CAD-RADS® weighted kappa.
Physician Tip

DEEPVESSEL Plaque offers quantitative plaque assessment from CCTA data, providing detailed measurements of different plaque types and stenosis categorization. This can be valuable for comprehensive coronary artery assessment and risk stratification.

DEEPVESSEL Plaque is part of a comprehensive CCTA analysis platform that also includes DEEPVESSEL FFR for functional assessment of coronary artery disease.

Details

Category Cardiology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud-based
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Cardiothoracic Surgery, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate DEEPVESSEL Plaque

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for DEEPVESSEL Plaque.

View all on YouTube

Frequently Asked Questions

DEEPVESSEL Plaque characterizes and quantifies coronary plaque and stenosis from previously acquired CCTA data, providing quantitative measurements and visual clinical reports.
DEEPVESSEL Plaque is designed to support qualified clinicians in coronary artery assessment.
DEEPVESSEL Plaque works with previously acquired CCTA data to analyze coronary plaque and stenosis.
No, DEEPVESSEL Plaque provides quantitative plaque assessment and stenosis analysis, while DEEPVESSEL FFR provides functional assessment.
DEEPVESSEL Plaque provides quantitative measurements and visual clinical reports for coronary plaque and stenosis.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-09-23 | First Added: 2026-09-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.